chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The night after she got the vaccines, she felt her arm was warm and she had pain. She took TYLENOL (325mg) that night. She slept for most of 2 days. Came in to the store. Her arm is very red and warm in 2 places Near both injection sites). Is swollen near the pneumonia site. Still has pain.
Fine tremor at rest and with intention to LUE/hand; pain and paresthesia onset 1 day after vaccine, tremor 2 days after vaccine
BENIGN VERTIGO/ON AND OFF LIGHTHEADEDNESS/FEELING WEIRD; TIREDNESS/FATIGUE; CHILLS; FEVER; This spontaneous report received from a patient concerned a 27 year old male. The patient's weight was 62 kilograms, and height was 69 inches. The patient's past medical history included fat removal from chest, and concurrent conditions included gastrooesophageal reflux disease, somewhat of a hypochondriac, penicillin allergy, and alcoholic, and other pre-existing medical conditions included patient had allergy to all NSAIDS (non-steroidal antiinflammatory drugs). patient had no drug abuse or illicit drug usage. patient consumed one small glass of red wine at night as a preventative for blood clots on the recommendation of a friend who is doctor and the alcohol also thins blood. The patient experienced drug allergy when treated with acetylsalicylic acid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 23-JUN-2021) dose was not reported, administered on 09-APR-2021 15:00 for prophylactic vaccination.  Concomitant medications included pantoprazole sodium sesquihydrate for gerd.  On APR-2021, Laboratory data included: Endoscopy (NR: not provided) unknown. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 39.5 C. On 10-APR-2021, the subject experienced tiredness/fatigue. Laboratory data included: Body temperature (NR: not provided) 38.5 C. On 16-APR-2021, the subject experienced benign vertigo/on and off lightheadedness/feeling weird. On 21-APR-2021, Laboratory data included: Neuro-ophthalmological test (NR: not provided) Benign vertigo. Treatment medications (dates unspecified) included: meclozine, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, and tiredness/fatigue on 12-APR-2021, and the outcome of benign vertigo/on and off lightheadedness/feeling weird was not reported. This report was non-serious.; Sender's Comments: MAC- V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Immediately following all 3 HPV injections, patient fainted. In October 2015 she started experiencing inexplicable digestive issues culminating in acute pancreatitis in January 2016. Been to many physicians, not one can tell us why.......
after 1st shot experienced flu like symptoms. 2 weeks after second dose, experienced breakthrough bleeding/spotting in menstrual cycle until period. Breakthrough bleeding/spotting stopped once actual menstrual cycle began 2 weeks later. No further issues until 9/1, breakthrough bleeding/spotting began again, extremely painful menstrual cycle. Menstrual cycle began on 9/5.
I started feeling a tingling/shooting pain going from my elbow up to my shoulder/underarm and down to my hand. I've never felt this before. It is still happening.  It happens several times a day. The only time I haven't noticed it happen is when I'm lying in bed.
feels flushed, lips tingling, reports feeling throat closing. Evaluated by EMS-Cleared
He totally turned into a diff child went from normal to autistic in a matter of 2 days after this shot was administered.
"Pfizer Covid19 Vaccine was administered 8/30/21 at Hospital. Body aches began the next day only lasting about 24 hours, three days of dizziness were followed afterwards, chest pain began around four or five days after first dose and has continually increased, chest feeling tight, heavy, burning and shortness of breath throughout each day, and possible heart palpations. I went to receive my second dose of the Pfizer Covid19 vaccine 9/20/21 and was instructed by nursing staff, who spoke with occupational health, to not receive my vaccine due to concern. I later spoke with occupational staff including Dr. who instructed me to make an appointment to get checked out. I have since had other problems such as swollen ankles and leg pain. The next day I went to an appointment at the Center where and ECG shown possible left atrial enlargement and a referral was made to see a cardiologist as soon as I could. I have updated occupational health since the appointment."
Information has been received on 15-NOV-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a healthcare provider at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. In 2016, the patient was treated by a healthcare provider at a clinic for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Like the soreness and stuff; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for Covid-19 immunization, reaction(s): "Slight soreness".  The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "Like the soreness and stuff". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: At the time the patient received it and he was a little concerned the way it was given, wasn't confident it was properly given and he contacted his PCP, he ordered a quantitative antibody test to see if it in fact (vaccination) did give some level of protection, agreed to do it, had the lab test.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
87-year-old overweight male with history type 2 diabetes mellitus, COPD on chronic prednisone at home, atrial fibrillation, anticoagulation Eliquis, BPH chronic indwelling Foley catheter, hypertension, anxiety, do not resuscitate code status.   Presented to the ED with complaints of shortness of breath for the past 1 week that has been gradually worsening especially with exertion.  Endorses sick contact in his son, with home he has been living, who currently has COVID-19 pneumonia and receiving ecmo.  Of note, patient was recently discharged from hospital on 06/29/2021 for acute hypoxic respiratory failure secondary to acute on chronic CHF exacerbation as well as AKI on CKD.  07/13/2021 tested positive 7/23/2021: patient discharged. Presented to the ED with complaints of shortness of breath for the past 1 week that has been gradually worsening especially with exertion.  Endorses sick contact in his son, with home he has been living, who currently has COVID-19 pneumonia and receiving ecmo.  Of note, patient was recently discharged from hospital on 06/29/2021 for acute hypoxic respiratory failure secondary to acute on chronic CHF exacerbation as well as AKI on CKD.   - ED workup significant for hypoxia 89% on room air, bradycardia 44-52, leukocytosis 19.95, elevated BUN 56, elevated serum creatinine 2.6 (bl. 1.3-1.4), hyponatremia 128 (137 on 7/7/2021), hyperkalemia 7.3.  ABG reveals 7.35/29.3/442/16.4.  Elevated lactic acid 2.3.  Normal anion gap.  Positive COVID-19 screen.   - Chest x-ray reveals cardiomegaly as well as blunting of the costophrenic angles compatible with small pleural effusions.  No vascular congestion or findings of pneumonia. - EKG shows Atrial fibrillation with slow ventricular response, right BBB.  Non acute.   Recent TTE revealed EF 55-6%, mild concentric LVH, aortic valve sclerosis, mild LA dilation, trace tricuspid regurgitation.
My mom said she didn't feel the same after the vaccine. On July 25 she started a new medication and had side effects to it. She was recently in the hospital on August 13 and they said she had a blood clot in her lung.
Adverse effect of vaccine, initial encounter  T50.Z95A E949.9      Left Arm   Patient's Medications   No medications on file   Discharge Instructions    Please apply warm compresses to the area of pain as often as possible to help improve circulation and resolve discomfort.   You may utilize acetaminophen 1 g 3 times daily if needed for pain or fever.   Please continue to utilize the left arm and perform range of motion as this will help resolve tenderness quickly.               40-year-old female presents with complaint of soreness to the left arm.  Patient received her first coronavirus vaccination approximately 1 week ago.  There was initially pain for several days but then resolved and now the pain has returned.  She describes the soreness as a pinching sensation rated 2?3/10 which does not radiate.  She has had no redness, warmth, ecchymosis or swelling at the site of the injection to the left deltoid.  Patient denies fever or chills and has had no cough, shortness of breath, dyspnea, chest pain or other symptoms.   Review of Systems  Constitutional: Negative.   Respiratory: Negative.   Cardiovascular: Negative.   Musculoskeletal: Positive for myalgias. Negative for arthralgias.  Skin: Negative for rash and wound.  Neurological: Negative.         No Known Allergies
Typical pox like vesicle rash - diagnosed by Dr. Less than 20 vesicles. Fever - 102.5.
Information has been received from a physician concerning an approximately 70 year old female with a history of strokes and no known allergies who during the week of 16-JUL-2007 was vaccinated subcutaneously with a 0.5 ml dose of Zostavax (Oka/Merck). Concomitant therapy included COUMADIN. On 20-JUL-2007 the patient returned to the office with a characteristic shingles rash with pain on her left breast. No labs were performed. At the time of this report the patient had not recovered. No additional information was provided. There was no product quality complaint involved. Additional information has been requested.
Pt called 3 day after receiving FLULAVAL injection stating she had developed a hive like rash and itching on her arms and legs several hours after receiving injection. She also c/o mild throat irritation and hoarseness, but no SOB, difficulty breathing. Rash was beginning to clear no fever noted.
she got COVID; she got covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 08Feb2021 as dose 1, single (Lot number: EM9809), on 01Mar2021 as dose 2, single (Lot number: EN6203), on 05Oct2021 as dose 3 (booster), single (Lot number: FF8839) and on 28Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset 07May2022, outcome "unknown", described as "she got COVID"; COVID-19 (medically significant) with onset 07May2022, outcome "unknown", described as "she got covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07May2022) Positive, notes: she used an at home test as well as went to Urgent care and did a Rapid Test and both tests were positive on the same day; (14May2022) Negative; (16May2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Caller states that she is calling about Paxlovid. She tested positive for COVID on 07May2022, after testing positive she started taking Paxlovid on the same day as well 07May2022. On the 14May2022 she tested negative, and then she felt okay. Then 2 days later on Monday 16May2022 she tested positive, at first she thought she had allergies but it got worse and worse feeling like a head cold with cough. Then last week she had horrible cough with a very sore throat, and slight fever. This week she really has a bad head cold. She's never heard of a relapse of COVID after taking Paxlovid and wants to know is it possible to have COVID after. She knows that she hasn't been anywhere and she still wears a mask. On some days she went to the market and still had a mask on. She would like to know if its possible to get a relapse infection after completion of paxlovid, or how do you get a relapse once you have completed paxlovid. Agent mentioned that she was filling an AE/PQC as the patient was fully vaccinated with COVID vaccine. Caller would like to know if she can take cough syrup with Codeine in it given that she has finished paxlovid few days ago. Caller also mentioned hat she did have the Pfizer COVID vaccine booster 6 days before she got COVID. She lost weight, she might be below 100lbs, she is maybe 99lbs.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
My arm started bleeding quite a bit during administration of the vaccine. About a week later I developed a severe rash on my face.
COVID 19 Treatment; COVID 19 Treatment; Interchange of COVID Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.1 (BNT162B2, BNT162B2 OMI BA.1), on 20Jan2023 at 12:00 as dose 6 (booster), single (Lot number: GJ67429) at the age of 52 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 22Mar2021 at 12:00 as dose 1, single (Lot number: ER8727), in right arm, on 12Apr2021 at 12:00 as dose 2, single (Lot number: ER8729), in right arm, on 18Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FF2593), in right arm and on 01Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FM0698), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 07Sep2022 at 12:00 as dose 5 (booster), single (Lot number: AS7144B) and on 16Sep2023 at 12:00 as dose 7 (booster), single (Lot number: NOVO3030371), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing), notes: managed with treatment.; "high cholesterol" (unspecified if ongoing), notes: managed with treatment. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 07Sep2022 at 12:00, outcome "unknown", described as "Interchange of COVID Vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Negative, notes: tested negative on day 9 after symptoms; (2023) Positive, notes: tested positive on day 11. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Patient received H1N1 shot and while waiting complained of feeling light-headed. She was observed and during the observation period she started experiencing chest tightness and started wheezing patient treated with Epi and Benadryl.
Extreme physical lethargy started after 18 hours, fever of 3.2 degrees over normal (101.8), chills.
Symptoms began on 3/24/21 and progressed until 3/28/21. Diagnosis is he suffered a spinal stroke, involving T6-T10. He is paralyzed from just below his nipple line, all the way down.
pt recvd vax;awakened at 2am 21feb w/ coughing,runny nose,T 101;dx: bronchospasms- cough w/ Bom;
After receiving Varicella vaccine on 4/16/09, pt was seen on 5/16/09 with a Dx of Varicella.
Patient with asthma, hyperlipidemia and recent COVID-19 vaccination who presents with episodes of self resolving chest pain shortness of breath as well as elevated troponin.   On exam, patient is well-appearing and speaking in full sentences.  Heart regular rate and rhythm and lungs are clear to auscultation bilaterally.  Abdomen soft, nontender nondistended.  No notable leg swelling or leg asymmetry on exam. Vital signs within normal limits, oxygen saturation of 99% on room air.  EKG normal sinus rhythm with a rate of 94, normal axis and intervals, no ST elevations or depressions. Differential diagnosis includes pulmonary embolism, myocarditis/pericarditis from recent COVID-19 vaccination, asthma.  Low suspicion for ACS at this time as patient is otherwise relatively healthy.  Heart score is 3.  Patient recently obtained a chest x-ray that was negative for pneumothorax, pneumonia, or other acute pathology.  Will hold off on repeat chest x-ray at this time.  Will obtain lab work including CBC, BMP, delta troponin, as well as D-dimer.  Will obtain bedside echo to evaluate for obvious pericardial effusion.
Within a few minutes of receiving first dose of Moderna Covid vaccine, I started experiencing acid reflux and it felt as if something was stuck in my throat. I thought it would have subsided by now, but have been experiencing a burning in throat and I am having to clear my through all day long. My throat has not felt the same since receiving the vaccine. I did a simple search and found that there are  a lot of other people with the same experience and thought I should report my experience.
Dizziness, shakiness, fever during class; came to health services, but was closed. Called campus police who called ambulance. Pt declined to go to hospital, was taken home. Woke up today feeling very sick, could hardly walk. Vomited twice. Came to health services, BP initially 98/32, no fever, no sx of anaphylaxis. Laid down and BP returned to wnl. Was given water and crackers. Had not eaten or voided since yesterday at 3 PM. Pt declined to got to hospital. Was able to ambulate by 4PM, vital signs within normal limits. Accompanied home by friend.
My ears were ringing,  I was sweating,   I felt a little faint, and I became light headed.
On Day 8 post vaccine I noticed there is redness and a little swelling at injection site. It is about  2 inches and slightly itchy.
Little bumps erupted on his arms and legs.   It was an itchy rash.  It started the day after the vaccination and continued through 10-13-21
G.I. problems; Arm was numb; This spontaneous case was received on 26-Oct-2020 from other non-health professional (consumer) via Med Communications (reference number: SEQW20-04239) and concerned a female patient of unreported age.    The patient's medical history and concomitant medications were not reported.     On an unknown date, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose, route of administration and anatomical location: not reported) for flu prevention. The batch number reported was 276571, expiry date: 30-Jun-2021.   On an unknown date, an unknown amount of time after receiving Flucelvax QIV, the patient's arm was numb and she had gastrointestinal (G.I.) problems.   On an unspecified date, two days after the onset, the patient recovered from 'numbness localised'.   The outcome of event 'gastrointestinal disorder NOS' was not reported.   The reporter did not provide causality assessment.   The reporter assessed the case as non-serious.   This case is linked to cases 202005552 and 202005553 (the same reporter).  Company comment: A female patient of unreported age was vaccinated with Flucelvax QIV. An unknown amount of time after receiving Flucelvax QIV, the patient developed hypoaesthesia (arm was numb) and gastrointestinal disorder (gastrointestinal problems). Causality cannot be excluded and is assessed as possibly related for both events.; Sender's Comments: A female patient of unreported age was vaccinated with Flucelvax QIV. An unknown amount of time after receiving Flucelvax QIV, the patient developed hypoaesthesia (arm was numb) and gastrointestinal disorder (gastrointestinal problems). Causality cannot be excluded and is assessed as possibly related for both events.
Episodes of generalized, unexplained anxiety with onset about 2 1/2 weeks after vaccination.  Episodes of anxiety are frequent and accompanied by tachycardia and high blood pressure.
Hospitalization after a fall resulting in femoral neck fracture. Patient deceased 3/4/21.
Vaccine given 11/3/03. States by 5 PM, diarrhea, nausea, dry heaves, malaise, headache, arms and shoulder ache. Continues on 11/4/03. No temp.
Myalgias, headache, weakness, achiness, dark urine, anorexia, urgency, frequency, fever of 103 degrees Fahrenheit, sharp left upper quadrant pain, arthralgias, diaphoresis, labile blood pressures and heart rates
Initial report received from a nurse on 22 June 2007.  A 15 month old, male patient (with a history of no known allergies, torticollis and 1 day cough and URI signs/symptoms) developed large welts and blotches at both injection sites, back, top of scalp, neck and cheek, within 5-10 minutes after receiving dose 4 of Tripedia (DTP-HIB) (reported US lot numbers UE827AA/U1857AA, corresponding sanofi pasteur SA lot number for Act-HIB (Y1096-3), intramuscularly in the left thigh and dose 4 of Prevnar (lot number B08679E) intramuscularly in the right thigh, on 22 June 2007.  Approximately 15 minutes post injection, there was increased swelling at the DTP-HIB site - left thigh.  The patient received 3/4 tsp Benadryl po.  Within 20 hours, welts were fading.  The patient was happy, active and did not have respiratory distress at any point.  It was reported the patient recovered.  The patient was previously evaluated by an allergist for hives after Hep B and flu shot.
By 9/3/04, pt states felt pain to left side of ace drooping occurred to eye and mouth left side. No ER services wee sought by patient. Did not return to Health Department or call until today 10/06/04, states resolved on own four days after onset, no relapse.